An unbalanced microbiome may lead to disease by creating aberrant immune responses. A recent association of cellular rejection with the development of interstitial fibrosis and tubular atrophy (IFTA) suggests the role of immune-mediated tissue injury. We hypothesized that developing IFTA correlates with altered urinary tract microbiomes (UMBs). UMBs at two serial time points, 1 and 6-8 months posttransplant, were assessed by 16S microbial ribosomal gene sequencing in 25 patients developing biopsyproven IFTA compared to 23 transplant patients with normal biopsies and excellent function (TX) and 20 healthy nontransplant controls (HC). Streptococcus, the dominant genera in HC males, was lower in IFTA and TX males at 1 month compared to HCs. At 6-8 months, Streptococcus was further decreased in IFTA males, but normalized in TX. IFTA males and females had increases in number of genera per sample at 6-8 months. UMB composition varied substantially between individuals in all groups. Despite the wide variation in UMBs between individuals, IFTA was associated with a loss in dominant resident urinary microbes in males, and a parallel increase in nonresident, pathogenic bacteria in males and females. UMB changes may contribute to IFTA development by alteration of the host immune response.
Introduction
The human microbiome, defined as the aggregate of microorganisms that inhabit the human body, likely plays a role in training and maintenance of the host immune response. The microbiome is important in human health (1) . Recent evidence suggests that altered or unbalanced microbial communities are associated with dysregulated immune responses (2, 3) that may contribute to the development of diseases such as inflammatory bowel disease (4, 5) , asthma (6) (7) (8) , and transplant rejection (9) . Sensitive DNA-based sequencing techniques have revealed the existence of bacteria in body areas originally believed to be sterile (10) (11) (12) , including the existence of a urinary tract microbiome (UMB) (13, 14) . Kidney transplantation alters the UMB by surgical stress, perioperative immunosuppression, and prophylaxis and/or therapy with antibiotics.
Interstitial fibrosis and tubular atrophy (IFTA) is a replacement of normal structures by interstitial fibrosis secondary to tissue injury. IFTA not associated with another known etiology (i.e. recurrent disease, BK nephropathy) occurs in %25% of 1-year surveillance transplant biopsies (15) (16) (17) as well as correlating with decreased graft survival (18) . Inflammation with histological evidence of IFTA has been correlated with increased graft loss (15, 17, (19) (20) (21) (22) (23) (24) . However, our latest data indicate that any case of histological IFTA represents a risk for immune-mediated graft loss (18) . Thus, we believe that IFTA is the result of chronic rejection and there is an etiologic role confirmed by molecular analysis of biopsies and immune pathway mapping of differentially expressed genes for both T cell and antibodymediated immune mechanisms.
Independent of immunosuppression, infections of the urinary tract or posttransplant alterations of the UMB may well lead to additional immune dysregulation and consequent immune-mediated graft injury. In fact, two recent papers from our laboratory group demonstrate that antibodies produced by B cell clusters commonly found in the biopsies of IFTA subjects are not recognizing donor HLA antigens but rather are specific for Escherichia coli Lipopolysaccharide, a powerful immune activator through the canonical TLR4 receptor (26, 27) . Another of our studies identified the role of a new mycoplasma protein, obtained from a potential human urinary pathogen, as a powerful, polyclonal B cell activator (27) . In the present study, we aimed to determine whether posttransplant changes in the UMB were correlated with biopsy-proven IFTA samples without a known etiology (i.e. chronic rejection).
DNA sequencing of bacterial 16S rRNA was used to assess the UMBs in 25 patients at 1 and 6-8 months posttransplant that demonstrated development of IFTA by surveillance biopsies and 23 patients enrolled in parallel but with normal biopsies and excellent function (TX) at both time points. UMBs were also obtained on 10 healthy male and 10 healthy female nontransplant volunteers. We found that the UMBs of healthy males and healthy females were different and each contained a relatively small number of dominant microbial species. In contrast, UMBs in the transplant patients were more complex and evolved over time in a way that correlated with the development of IFTA. We theorize that posttransplant alterations of the UMB may contribute to IFTA development by dysregulated stimulation of the host immune system secondary to disruption of normal microbiomes or replacement of bacteria in genitourinary niches with pathological bacteria.
Methods

Study population
Clean-catch urine samples were obtained from 25 patients at two time points after transplantation: approximately 1 month and 6-8 months. These patients demonstrated development of IFTA on 6-8-month surveillance biopsies compared to their biopsies done at 1 month. Moderate to severe IFTA was defined according to the Banff 2007 schema as tubulointerstitial changes in >25% of the cortical area examined. Cases where these changes could be linked to known mechanisms of kidney injury such as recurrent or concomitant disease were excluded. Urine samples at the same time points were obtained from 23 patients with normal surveillance biopsies and stable kidney function (TX). These samples were collected at Emory University with Institutional Review Board approval. Additional urine samples were obtained from 10 healthy male and 10 healthy female nontransplant volunteers to determine normal microbial populations. The only exclusions to study entry were individuals with biopsies that did not conform to the study's inclusion/exclusion criteria for IFTA with unknown cause (Data S1), such as the presence of BK nephritis or recurrent disease. Biopsies with borderline changes, higher grades of T cell/antibodymediated rejection, or focal/minimal C4d were all excluded.
Statistical analysis
Analysis of variance or Pearson's chi-square tests were used to detect differences in continuous and categorical variables between phenotypes. All p-values were adjusted with Bonferroni correction for multiple hypothesis testing when appropriate.
16S microbial ribosomal DNA sequencing
A minimum of 50 mL of urine was spun for 30 min at 1800g before adding 1 mL of RNAlater (Qiagen Inc., Valencia, CA) to the pelleted sample and storing at À80°C. 
Normalization of count data
For each urine sample, the number of reads that mapped to each bacteria phyla, classes, orders, families, and genera were totaled. These bacteria read counts were divided by the total number of reads mapped in each sample (i.e. number of bacteria-specific sequence/total number of sequences mapped for a sample) (28) (i.e. normalization). These fractions were converted to percentages, providing a bacteria composition for each sample.
Results
UMBs were assessed at 1 month and then again approximately 6-8 months posttransplant. UMBs were also obtained on 10 healthy male and 10 healthy female nontransplant volunteers to establish the composition of normal UMBs. The IFTA group had a higher percentage of African Americans than TX (68% vs. 57%, p = 0.04). The study overall contained more males than females, but no differences in the percent of females in comparison of IFTA versus TX groups (Table 1 ). There were also no differences in age, immunosuppressive regimen, EpsteinBarr virus and cytomegalovirus positivity, and incidence of type 1 or type 2 diabetes. The immunosuppressive regimen was the standard of care for Emory's transplant program: basiliximab induction followed by tacrolimus, mycophenolate mofetil, and prednisone maintenance.
Microbiome differences in male versus female healthy nontransplant controls There were no statistically significant differences in bacterial compositions at the level of phyla for comparisons of UMBs in male versus female healthy controls. Firmicutes made up 65% of male versus 73% of female UMBs. The following phyla combined with Firmicutes to comprise near 97% of all phyla in healthy men and women: Actinobacteria (15% males vs. 19% females), Bacteroidetes (10% males vs. 3% females), and Proteobacteria (8% males vs. 3% females).
In contrast, there were statistically significant differences between males and females at the bacteria genus level. In healthy male controls, 10 genera comprised over 90% of the bacterial population. The top five bacteria in order of abundance were Streptococcus (31%), Lactobacillus (23%), Prevotella (10%), Corynebacterium (9%), and Pseudomonas (4%). In the healthy female controls, 10 genera comprised over 94% of the bacteria population. The top five bacteria in females according to prevalence were Lactobacillus (63%), Corynebacterium (11%), Gardnerella (8%), Prevotella (3%), and Bacillus (2%). Figure 1 plots the composition of genera in healthy males versus females. There was a statistically higher percentage of lactobacillus in females compared to males (p = 0.01). Alternatively, there was a statistically higher amount of Streptococcus in males (p = 0.006).
It is important to note that we observed a high variability in bacterial genera composition between individuals. This was true for healthy controls and all the transplant patient microbiomes ( Figure 2 ). As mentioned, Streptococcus was collectively the most abundant genera in healthy males, yet it was the dominant genera in only 50% of samples. Lactobacillus was collectively the most abundant genera in healthy females, and was the dominant genera in 80% of samples.
Microbiome at 1 month posttransplant for IFTA and TX samples There were differences at the genera level in UMBs from IFTA and TX samples at 1 month posttransplant in comparison to healthy controls ( Figure 3 ). The considerable variability observed between individuals within the same phenotype made it difficult to statistically detect differences in collective microbiome populations.
In females, Lactobacillus was nonsignificantly lower in IFTA (48%) and TX (45%) compared to healthy controls (63%; p = 0.20 and p = 0.24, respectively) ( Figures 4A  and B ). There was also a nonsignificant increase in Gardnerella from TX females compared to healthy control females (13% vs. 8%, p = 0.14). In males, Streptococcus was significantly lower in IFTA (11%) and TX (6%) patients compared to healthy controls (32%; p < 0.058 and p = 0.05, respectively) ( Figures 4C and D) . The percent composition of Lactobacillus was lower in TX (10%) compared to healthy controls (24%) but was not significant, again due to individual variation.
In comparison of female IFTA versus TX at 1 month, there were no statistically significant differences in UMBs. Lactobacillus was the dominant genus in both IFTA (49%) and TX (45%) ( Figure 5A ), and there was a similar percent of Gardnerella, Prevotella, and Corynebacterium. There were Missing data: Type 1 diabetes (n = 3, 6%), Type 2 diabetes (n = 2, 4%), cytomegalovirus (CMV) serology (n = 1, 2%), Epstein-Barr virus (EBV) serology (n = 1, 2%), tacrolimus treatment (n = 2, 4%), mycophenolate treatment (n = 5, 10%). 2 Analysis method: analysis of variance for quantitative data (probability > F statistic), Pearson's chi-square test for dichotomous data. also no statistically significant differences in comparison of male IFTA versus TX at 1 month ( Figure 5B ). There was no dominant genus in either IFTA or TX. Corynebacterium had the highest abundance of any genus, comprising 24% of TX males and 9% of IFTA males.
Microbiome at 6-8 months posttransplant for IFTA and TX samples In TX females, Lactobacillus was relatively nonchanged (45-47%) from 1 to 6-8 months, and nonsignificantly lower than normal control females (63%) ( Figure 6A ). In contrast, in IFTA females, Lactobacillus decreased further from 48% to 36%, which was also lower than normal controls (63%; p = 0.06) ( Figure 6B ). In male TX patients, Streptococcus increased from 6% at 1 to 36% 6-8 months posttransplant, returning to the level of healthy controls (32%, p = 0.98) ( Figure 6C ). Meanwhile, in male IFTA patients, Streptococcus decreased from 11% at 1 to 3.4% at 6-8 months posttransplant, and was significantly lower than healthy control males (p = 0.03) ( Figure 6D ).
In comparison of female IFTA versus TX at 6-8 months, there were no statistically significant differences in UMBs. Lactobacillus was the dominant genus in both IFTA (36%) and TX (47%), followed by Gardnerella and Prevotella ( Figure 7A ). Corynebacterium, which was present in both IFTA and TX females at 1 month, was not found at significant abundance at 6-8 months.
In comparison of male IFTA versus TX at 6-8 months, there was a significantly higher abundance of Streptococcus in Figure 2 : Bacteria genera composition (percent) for each individual. Most of the male healthy controls (HC) (top row, left) have dominance by Streptococcus (purple) and/or Lactobacillus (red). Most of the female HCs (top row, right) are dominated by Lactobacillus (red) genera. In the transplant patients, there is a decrease in the dominant bacteria at 1 month posttransplant (second row). At 6 months posttransplant (third row), there is a general restoration of dominant bacteria in the treatment group with excellent functioning kidney (TX) participants. In contrast, there is a further decrease in normally dominant genera in interstitial fibrosis and tubular atrophy (IFTA) participants from 1 to 6 months posttransplant. Despite these generalized findings, this image makes it apparent that there exists significant variation in bacteria genera composition in every phenotype. TX (mean: 36% vs. 3%, p = 0.03) ( Figure 7B ). Of note, the range and 25th-75th quartile of Streptococcus in TX was 0-99% and 1-74%, respectively, compared to 0-12% and 0-6% in IFTA ( Figure S1 ). There was an increase in Gardnerella in IFTA compared to TX of borderline statistical significance (12% vs. 2%; p = 0.06). Otherwise, there was no difference in Corynebacterium, Lactobacillus, and Prevotella. (top row, left) . Lactobacillus (dark blue) has the highest average abundance in HC females (top row, right). At 1 month posttransplant (second row), both treatment group with excellent functioning kidney (TX) and interstitial fibrosis and tubular atrophy (IFTA) males and females demonstrate a decrease in Lactobacillus and Streptococcus genera, with an increase in nondominant species. At 6 months (third row), there is restoration of dominant bacteria (i.e. Lactobacillus and Streptococcus) in TX, but a further loss of these two genera in the IFTA patients.
Number of genera per sample is increased in IFTA samples At 1 month posttransplant, there was no significant difference in the number of genera per individual as a function of IFTA versus TX patients and IFTA versus healthy controls (Figure 8 ). In contrast, by 6-8 months, IFTA patients demonstrated a significant increase in the number of genera per individual (median = 41.5) in comparison to healthy controls (median = 20.5; p-value = 0.05) and TX at 6-8 months (median = 19.5; p-value = 0.02).
Discussion
In this study, we determined UMB compositions of 48 transplant patients at 2 time points (1 and 6-8 months posttransplant) and 20 healthy controls to determine microbiome changes associated with the development of IFTA. We found that healthy control female microbiomes were dominated by the Lactobacillus genus, whereas healthy control males comprised mostly the Streptococcus genus. In comparison to healthy controls, all transplant had a collective decrease in normal resident genera at 1 month posttransplant. This change from normal may reflect the common use of antibiotics, including prophylaxis, in the early posttransplant period. It is also possible that UMBs are impacted by the first exposure to immunosuppressive drugs and a major surgical procedure. Finally, there could be disturbance of the normal urinary microbiome prior to transplantation due to the presence of chronic kidney disease. Thus, transplantation and the use of immunosuppressant and antibiotic medications may be further worsening an already dysregulated UMB. The clinical significance of this study is that a future prospective trial may demonstrate that monitoring urinary microbiome changes in individual patients as a function of time and selective treatment may reduce susceptibility to rejection, including chronic rejection and development of IFTA, and ultimately improve long-term clinical outcomes.
At 6-8 months posttransplant, Lactobacillus stabilized in females with healthy grafts (TX) but decreased in females with histological evidence of IFTA. Similarly, Streptococcus actually increased to normal levels in TX males from 1 to 6-8 months posttransplant, but decreased to represent only 3.4% in the IFTA group. Concurrently, we found that the number of genera per sample was significantly higher in IFTA patients at 6-8 months compared to all transplant patients at 1 month, TX patients at 6-8 months, and all healthy controls. In addition to these collective differences in microbiome composition, it is important to note that we also observed a high variability between individual samples, even within the same phenotypic group. Therefore, we conclude that this approach is not appropriate for developing a biomarker strategy based simply on 16S microbial ribosomal gene profiling signatures.
Bacterial DNA sequences taken from the urine of our 10 healthy females were predominantly found in the following phyla: Firmicutes (73%), Actinobacteria (19%), Bacteroidetes (3%), and Proteobacteria (3% females). In a prior study that evaluated the urinary microbiomes in eight healthy females by also using 16S sequencing methods, the authors reported UMB compositions that were very similar to our female patients: Firmicutes (65%), Bacteroidetes (18%), Actinobacteria (12%), Fusobacteria (3%), and Proteobacteria (2%) (29) . The phyla composition of the male healthy controls in our study was also very similar to our female subjects and the previous study: Firmicutes (66%), Actinobacteria (15%), Bacteroidetes (10%), and Proteobacteria (8%). Finally, in a similarly designed study featuring both adult men (n = 6) and women (n = 10), three quarters of the samples had Firmicutes (30) as the predominant phylum. All of these findings suggest that Firmicutes is the dominant and relatively stable phylum in the UMB of both healthy men and women, followed by three other less prevalent bacterial phyla: Actinobacteria, Bacteroidetes, and Proteobacteria.
Notwithstanding strong similarities at the phyla level, healthy males and females differed substantially at the genus level in our study. The urine of our female healthy controls included the following genera: Lactobacillus (63%), Corynebacterium (11%), Gardnerella (8%), Prevotella (3%), and Bacillus (2%). In contrast, the urine of our male controls included the following genera: Streptococcus (31%), Lactobacillus (23%), Prevotella (10%), Corynebacterium (9%), and Pseudomonas (4%). Supportively, in the study of eight urinary microbiomes from healthy females mentioned previously, the authors found the following three genera to be of highest abundance: Lactobacillus (57%), Prevotella (20%), and Gardnerella (10%). Corynebacterium was not found in healthy UMBs in the published study, although this may be due to differences in sequencing techniques and read mapping. For example, the researchers sequenced three regions of the rRNA (V1, V2, and V6), whereas our technique sequenced seven regions of the rRNA (V2, V3, V4, V6, V7, V8, and V9). We also mapped gene sequences to later versions of microbial databases.
In another published study, the authors used 16S sequencing to evaluate UMBs of 26 healthy controls and 27 subjects at risk for asymptomatic bacteriuria due to spinal cord injury-related neurogenic bladder (31) . In agreement with our results, Lactobacillus was higher and the predominant genera in healthy women, while Streptococcus was higher in healthy males. The study found that Lactobacillus, Corynebacterium, Gardnerella, Prevotella, and Enterococcus defined gender differences. Finally, the authors concluded that there was decreasing abundance of Lactobacillus in relation to increasing duration of a neurogenic bladder. Concurrently, Enterobacteriales also increased in abundance in relation to neurogenic bladder duration. The authors concluded that the loss of Lactobacillus dominance and increase of Enterobacteriales likely predisposed these individuals to urinary tract infections. This parallels our results in female transplant recipients with IFTA in which levels of Lactobacillus decrease by 6-8 months.
It is worth noting that the Streptococcus and Lactobacillus genera identified in our study are actually from the same bacteria order (Lactobacillales) and phylum (Firmicutes). That explains why there were no differences in healthy control males versus females at the phyla level. The evolutionary closeness between these two genera suggests that these bacteria have evolved in parallel and adapted to the role as primary human commensal organisms in the genitourinary space. Within the genera of Streptococcus, we identified two known commensal species commonly found in healthy individuals: S. anginosus and S. intermedius. Likewise, within the Lactobacillus genera in females, we found the following three commensal species: L. iners, L. jensenii, and L. vaginalis. Combining Streptococcus and Lactobacillus, we found that these two genera comprise the vast majority of urinary microbiomes in all healthy men and women. While cognizant of the large variability in genera between individuals, we found that the collective abundance of Streptococcus was significantly lower in all male transplants at 1 month posttransplant in comparison to healthy controls. We also found that Lactobacillus was nonsignificantly lower in all transplant patients compared to healthy controls at the same time point. An important finding of our study is that Streptococcus further decreased to only 3.4% in males with biopsy-proven IFTA, but actually increased to normal levels in male transplants with biopsy-documented normal histology and normal renal function (TX). Similarly, Lactobacillus decreased to 36% in females with IFTA, but stabilized in the TX females at 47%, although this did not reach statistical significance. Concomitantly, there was a significant increase in the number of genera or microbial complexity per sample in the male and female IFTA samples at 6 months in comparison to all the TX samples and healthy controls. The increase in the number of genera per sample represents a replacement of the dominant bacteria (i.e. Lactobacillus and Streptococcus) with a multitude of nonresident bacteria, many of which are known to be pathogenic ( Table 2 ). Studies that provide evidence that these nonresident bacteria species can cause infection in transplant patients, or elicit an immune response, are also referenced in Table 2 .
In the months after kidney transplant surgery, there are alterations in the host microbiome in relation to exposure to hospital microbes, administration of perioperative and prophylactic antibiotics, and initiation of immunosuppressive medications (14) . These published changes in the host microbiome as a function of time posttransplant, including our new data on the urinary microbiome in patients developing IFTA, suggest that the replacement of dominant bacteria with nonresident bacteria is likely influencing the immunobiology of the transplant but may also impact the overall clinical health of the transplant recipient. Our recent publication demonstrated that molecular profiling of kidney transplant biopsies with IFTA shares a majority of both the genes and immune pathways found in biopsies of patients with clinical acute rejection (18) . We concluded that IFTA is part of the arc of the same immune-mediated rejection process; in other words, IFTA is a histological feature of chronic rejection. Therefore, given the new data in this report on the UMB, we propose that chronic, immune-mediated rejection is influenced directly and/or indirectly by the changing microbial populations in the genito-urinary tract. In a study that characterized the vaginal microbiota of 396 asymptomatic, sexually active women using 16S sequencing, the most abundant vaginal bacteria genera were Lactobacillus, Prevotella, Megasphaera, Sneathia, Atopobium, and Streptococcus (32) . In all the female participants of our study, Lactobacillus, Prevotella, and Streptococcus were among the top five most abundant UMB bacteria genera. Thus, given the known propensity for urine collection to be contaminated by vaginal flora, there remains a possibility that some of our UMB findings are a reflection of normal vaginal flora. Notwithstanding, these three bacteria genera were also among the top five abundant bacteria in healthy control males and transplanted male patients.
Alternatively, it is likely that maintenance of the Lactobacillus genus, whether as the dominant bacteria in UMB or vagina flora, has a correlation with overall health of the host. Lactobacillus is a facultative anaerobe that dominates the vaginal environment in women of reproductive age, and is important in maintaining an overall acidic environment (32) . The maintenance of Lactobacillus as the dominant species has been consistently associated with healthy pregnancy outcomes and prevention of infections, including sexually transmitted pathogens such as human immunodeficiency virus (33) , and a condition known as bacterial vaginosis. Bacterial vaginosis is a type of vaginal inflammation in which atypical bacteria such as Gardnerella replace Lactobacillus and other dominant vaginal resident bacteria. In a study of 231 vaginal samples, the molecular quantification of Atopobium vaginae and Gardnerella vaginalis by DNA levels had the highest predictive value for the diagnosis of bacterial vaginosis with a 99% sensitivity (34) . Bacterial vaginosis consistently associates with preterm labor complications and worse pregnancy outcomes (24) . In addition to protection from the influence of potential pathogenic bacteria, Lactobacillus likely plays an important role in tempering the immune response. Indeed, in a mouse model of graft-versus- Literature citations are provided for bacteria species that have demonstrated the ability to produce infection or cause immune stimulation. Note: No specie (NA) is given in cases where the majority of the reads are unable to be mapped to a bacteria specie (i.e. "slash reads").
host disease, replenishment of the dominant Lactobacillus species in the gut significantly protected mice from disease (35) .
A number of other limitations must be acknowledged. First, the high level of interindividual variation we document in the urinary microbiomes obviates thinking about this work in simple biomarker or molecular diagnostic terms. Perhaps monitoring individual changes and/or identifying specific classes of microbiota associated with increased risk for chronic rejection might eventually prove valuable. Second, the current early state of microbiome research makes any kind of mechanistic conclusions with the profiling results of human patient samples impossible. Are the changes we observe due to changes in transplant function with chronic rejection? Or is there a link between urinary microbiome changes with altered and/or activated immune effector cell populations? Third, since urine collection in females can often be contaminated with vaginal flora, the UMBs of healthy and transplant females may have been biased to demonstrate an increased prevalence of vagina flora, making it more difficult to identify IFTA-specific microbial changes.
In conclusion, unbalanced microbial communities have been associated with dysregulated immune responses (2,3) and the development of inflammatory diseases such ulcerative colitis, Crohn's disease, and asthma. Interestingly, several studies including our own recent work (17) now demonstrate an association of cellular immune rejection with the development of IFTA (15, 17, (19) (20) (21) (22) (23) (24) , suggesting that dysregulated immune responses may also be responsible for chronic rejection. Our theory is that the loss of protective, typically predominant resident bacteria and replacement with pathogenic nonresident bacteria in the UMB is acting to increase the immune response towards the transplanted kidney. This upregulation of the immune system is then leading to nonspecific graft injury and exacerbating the specific immune response against the allograft in a feedforward activation mechanism. The clinical significance of this study is that a future prospective trial may demonstrate that monitoring urinary microbiome changes in individual patients as a function of time and selective treatment may reduce susceptibility to rejection, including chronic rejection and development of IFTA, and ultimately improve long-term clinical outcomes. Finally, there is much to learn about how the microbiome in different tissues influences the immune repertoire and with that understanding should emerge additional and novel opportunities to prevent or treat human disease.
